Elevance Health (ELV) Revenue (2009 - 2026)

Elevance Health (ELV) has 18 years of Revenue data on file, last reported at $41.3 billion in Q2 2026.

• On a quarterly basis, Revenue changed 0.02% year-over-year to $41.3 billion in Q2 2026; TTM through Jun 2026 was $182.1 billion, a 22.38% increase from a year earlier, with the FY2025 full-year figure at $199.1 billion, up 38.12% from the prior year.
• Revenue for Q2 2026 stood at $41.3 billion, up from $41.0 billion in the prior quarter.
• Over the last five years, Revenue for ELV reached as high as $63.6 billion in Q4 2023 and fell as low as $14.0 billion in Q4 2024.
• Historically, Revenue has averaged $40.6 billion across 5 years, with a median of $41.6 billion in 2023.
• Across the five-year window, Revenue jumped 269.13% in 2023 and tumbled 78.07% in 2024, its largest moves.
• Year by year, Revenue stood at $17.2 billion in 2022, then soared by 269.13% to $63.6 billion in 2023, then tumbled by 78.07% to $14.0 billion in 2024, then soared by 256.58% to $49.7 billion in 2025, then decreased by 17.02% to $41.3 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $41.3 billion in Q2 2026, $41.0 billion in Q1 2026, and $49.7 billion in Q4 2025.